SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is trending amidst extreme price volatility, with recent declines prompting a polarized community debate between those who see a generational buying opportunity at key support levels and others forecasting further drops, intensified by prevailing FUD narratives and large institutional moves.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is trending after announcing a cheaper, compounded oral semaglutide offering, sparking immediate threats of legal and regulatory action from Novo Nordisk, which accuses HIMS of illegal mass compounding and patient safety risks. The community is sharply divided, with bulls viewing HIMS as a healthcare disruptor challenging big pharma's pricing and operating within legal compounding frameworks, while bears warn of significant legal and financial repercussions, questioning the company's long-term viability and ethics.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including from sellers, advertising, and subscription services through internationally-focused online stores. The AWS segment is composed of global sales of compute, storage, database, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon.com is experiencing a significant market downturn after its latest earnings report highlighted a massive projected capital expenditure for AI and cloud infrastructure, overshadowing strong AWS growth. The community is sharply divided, with some investors seeing a buy opportunity in these strategic future investments, while others express concern over immediate margin pressures and question the magnitude of the spending.

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

Mounting geopolitical concerns in the Middle East, a sharp downturn in major tech stocks following earnings, and a significant crypto market correction are driving SPY's trend, with the community fiercely debating whether this signals a deeper market collapse or a "face-ripper" rebound.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is trending following an earnings miss heavily impacted by lower Bitcoin prices and one-time accounting charges, causing a significant stock sell-off. While the community debates this "price chaos" against the long-term AI infrastructure thesis, many highlight the company's substantial secured power capacity and funding for its AI pivot, despite current revenue generation challenges.

Stellantis NV engages in the designing, engineering, manufacturing, distributing, and selling of vehicles and components. It offers its products under the Abarth, Alfa Romeo, Chrysler, Citroën, Dodge, DS Automobiles, Fiat, Jeep, Lancia, Maserati, Opel, Peugeot, Ram Trucks, Vauxhall, Free2move, and Leasys brands. The company was founded on April 1, 2014 and is headquartered in Hoofddorp, the Netherlands.

Stellantis N.V

Stellantis is experiencing a significant drop following news of a multi-billion dollar charge tied to a business overhaul and an EV strategy reset, igniting intense community discussion on its valuation and sustainability as it navigates recalls and a challenging auto market.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

NBIS is trending as a broader tech sell-off and "AI bubble" concerns create volatility, even as hyperscalers like Amazon and Google announce hundreds of billions in new data center CapEx. Investors are actively discussing whether the current dip is a strong buying opportunity for NBIS, a pure-play AI data center provider, ahead of its upcoming earnings and confirmed expansion projects, emphasizing its distinction from crypto-linked companies.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Holdings Inc

Ondas Holdings is experiencing a massive sell-off, largely attributed by the community to broader market weakness and aggressive short pressure, despite recent positive news regarding strategic acquisitions, defense contract wins, and its unique FAA and Blue UAS certifications. Many long-term investors are seizing the opportunity to buy the dip, confident in the company's future in the burgeoning drone and defense sector.

Innodata, Inc. is a data engineering company, which engages in providing artificial intelligence software platforms and management of its services. It operates through the following business segments: Digital Data Solutions (DDS), Synodex, and Agility. The DDS segment combines deep neural networks and human expertise in multiple domains to make unstructured information useable. The Synodex segment enables clients in the insurance and healthcare sectors to transform medical records into useable digital data and to apply technologies to the digital data to augment decision support. The Agility segment provides tools and related professional services that enable public relations and communications professionals to discover influencers, amplify messages, monitor coverage, and measure the impact of campaigns. The company was founded by Todd H. Solomon in 1988 and is headquartered in Ridgefield Park, NJ.

Innodata Inc

Innodata is significantly trending following its strategic partnership with Palantir Technologies for AI data engineering services and securing a prime contract position on the U.S. Missile Defense Agency's SHIELD program. The community is actively discussing these developments as major catalysts, positioning INOD as essential for defense, government, and sovereign AI, fueling strong speculation around substantial revenue growth and potential acquisition within the booming AI data training sector.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. It provides online news services where users can select and rank web content. The firm also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Reddit (RDDT) is trending after reporting a significant beat on Q4 2025 earnings, showcasing impressive revenue growth and strengthened profitability, coupled with the announcement of a $1 billion share repurchase program. The community is actively discussing the strong financials as a catalyst for a potential short squeeze and a rebound from recent market pressures.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Celldex Therapeutics Breaks Below 200-Day Moving Average - Notable for CLDX

In trading on Thursday, shares of Celldex Therapeutics, Inc. (Symbol: CLDX) crossed below their 200 day moving average of $23.76, changing hands as low as $23.61 per share. Celldex Therapeutics, Inc...

Celldex Therapeutics, Inc. (NASDAQ:CLDX) Given Average Recommendation of "Moderate Buy" by Brokerages

Shares of Celldex Therapeutics, Inc. (NASDAQ:CLDX - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the ten brokerages that are covering the company, MarketBeat.com...

Celldex Therapeutics, Inc. (NASDAQ:CLDX) Sees Large Growth in Short Interest

Celldex Therapeutics, Inc. (NASDAQ:CLDX - Get Free Report) was the target of a large increase in short interest in the month of December. As of December 31st, there was short interest totaling...

Celldex Therapeutics (NASDAQ:CLDX) Trading Down 7.5% - Here's Why

Celldex Therapeutics (NASDAQ:CLDX) Stock Price Down 7.5% - Should You Sell...

Celldex Therapeutics SVPs Engage In Heavy Transactions

Key PointsFreddy A. Jimenez directly sold 4,166 shares for a transaction value of $121,210 on Dec. 4, 2025...

Celldex Therapeutics, Inc. (NASDAQ:CLDX) Given Consensus Rating of "Moderate Buy" by Analysts

Celldex Therapeutics, Inc. (NASDAQ:CLDX - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the eleven research firms that are covering the stock, Marketbeat...

Celldex Therapeutics (NASDAQ:CLDX) Trading 4.1% Higher - Should You Buy?

Celldex Therapeutics (NASDAQ:CLDX) Shares Up 4.1% - Here's Why...

Simplify Asset Management Inc. Invests $2.20 Million in Celldex Therapeutics, Inc. $CLDX

Simplify Asset Management Inc. purchased a new position in shares of Celldex Therapeutics, Inc. (NASDAQ:CLDX - Free Report) during the third quarter, according to its most recent Form 13F filing with...

Short Interest in Celldex Therapeutics, Inc. (NASDAQ:CLDX) Declines By 20.9%

Celldex Therapeutics, Inc. (NASDAQ:CLDX - Get Free Report) was the recipient of a large decrease in short interest during the month of December. As of December 15th, there was short interest totaling...

Celldex Therapeutics (NASDAQ:CLDX) Stock Price Crosses Above Two Hundred Day Moving Average - Here's What Happened

Celldex Therapeutics (NASDAQ:CLDX) Stock Price Crosses Above 200 Day Moving Average - Time to Sell...

Celldex Therapeutics, Inc. engages in the business of development, manufacturing and commercialization of novel therapeutics for human health care. Its drug candidates have the ability to engage the human immune system and directly inhibit tumors to treat specific types of cancer and other diseases. Its pipeline includes Varlilumab, CDX-1140, and CDX-301, and CDX-3379. The company was founded by Anthony S. Marucci and Tibor Keler in 1983 and is headquartered in Hampton, NJ.

CLDX
Celldex Therapeutics Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CLDX News

CLDXCelldex Therapeutics Inc.